Rhogam and AIDS
FDA and CDC have concluded that Ortho's plasma product for RH disease did not cause a woman, who had tested positive for AIDS, to become infected with the virus ("The Pink Sheet" Oct. 12 "In Brief"). The agencies determined that "the alcohol fractionation method used in preparing Rhogam would inactivate any virus that might be present and there are other, more likely sources of the AIDS virus for this woman." FDA and CDC recommend that facilities awaiting results of the investigation resume using Rhogam.
You may also be interested in...
The number of new drugs containing new active substances approved in the EU rose significantly in 2020, underpinned by a strong showing for orphan-designated products and a string of novel medicines for cancer and infectious diseases. Notable among the new clutch of approvals was the first ever COVID-19 vaccine, Pfizer/BioNTech's Comirnaty.
The Canadian medtech regulator has recommended updating its list of recognized medical device standards that manufacturers can rely on to demonstrate compliance with local safety, effectiveness and labeling requirements.
Our graphic tracker of key developments from emergency authorized vaccines, the global roll-out, and late-stage vaccine candidates.